Page last updated: 2024-09-03

3-n-methylspiperone and perospirone

3-n-methylspiperone has been researched along with perospirone in 1 studies

Compound Research Comparison

Studies
(3-n-methylspiperone)
Trials
(3-n-methylspiperone)
Recent Studies (post-2010)
(3-n-methylspiperone)
Studies
(perospirone)
Trials
(perospirone)
Recent Studies (post-2010) (perospirone)
155671112426

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwata, Y; Minabe, Y; Mori, N; Nakamura, K; Okada, H; Ouchi, Y; Sekine, Y; Sugihara, G; Suzuki, K; Takei, N; Tsuchiya, KJ; Yoshikawa, E1

Trials

1 trial(s) available for 3-n-methylspiperone and perospirone

ArticleYear
Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:5

    Topics: Adult; Antipsychotic Agents; Binding, Competitive; Brain; Humans; Indoles; Isoindoles; Male; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Reference Values; Spiperone; Thiazoles

2006